Clinical independent prognostic factors and overall survival prognostic nomogram for intracranial subependymoma: A SEER population-based analysis 2004–2016

Purpose This study was launched to ascertain the independent prognostic factors influencing the overall survival (OS) prognosis of intracranial subependymoma and construct a prognostic model to predict OS time. Materials and methods We collected data from patients with intracranial subependymoma, including treatment data, follow-up data, and clinical and pathological characteristics from the SEER database within 2004 to 2016, and patients were randomly classified into training and validation cohorts. Univariate and multivariate analyses were applied to the training group through building a Cox proportional hazards model. According to the results of multivariate analysis, we established a nomogram to forecast the OS rate of the per-case patient graphically, then calculated the accuracy of verification in both training and validation cohorts by concordance index (C-index). Univariate and multivariate analyses were used for different subgroups of unoperated versus operated, gross total resection (GTR), subtotal resection (STR), and biopsy after using the propensity score matching (PSM) analyses. Results A total of 667 patients were enrolled, and we randomly assigned 535 patients (80.21%) into the training cohort and 132 patients (19.79%) into the validation cohort. Age [hazard ratio (HR) = 6.355; 95% confidence interval (CI), 2.240–18.029; p = 0.001] and sex (HR = 0.475; 95% CI, 0.232–0.974; p = 0.042) were the independent prognostic factors in the training cohort. On the basis of age and sex, the nomogram was established to predict the OS for every patient (C-index = 0.733 ± 0.065 in the training cohort and 0.850 ± 0.065 in the validation cohort), and calibration plots reflected the reliability of the nomogram. Age, gender, or laterality was the independent prognostic factor for OS in the different matched subgroups of unoperated versus operated, GTR, STR, and biopsy. Surgical treatment, race, year of diagnosis, insurance, tumor location, tumor size, pathology, tumor grade, and radiation were not statistically significantly different in OS for subependymoma in our research. Conclusion Age and sex were the independent prognostic variables for OS in intracranial subependymoma. According to our research, we should not be more inclined to choose conservative or surgical treatment. Nonetheless, the information that we present might be useful to suggest potential hypotheses to be tested in the clinical research setting.

[1]  G. Reifenberger,et al.  The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. , 2021, Neuro-oncology.

[2]  K. Franz,et al.  Subependymomas – Characteristics of a “Leave me Alone” Lesion Subependymome – Charakteristika einer „leave me alone“-Läsion , 2018, RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.

[3]  A. Brodbelt,et al.  Surgical management and long-term outcome of intracranial subependymoma , 2018, Acta Neurochirurgica.

[4]  G. Mckhann,et al.  Subependymomas Are Low-Grade Heterogeneous Glial Neoplasms Defined by Subventricular Zone Lineage Markers. , 2017, World neurosurgery.

[5]  S. Shabani,et al.  Intracranial Subependymoma: A SEER Analysis 2004-2013. , 2017, World neurosurgery.

[6]  B. Greenwald The institutional experience , 2017 .

[7]  D. Geng,et al.  Neuroradiological features of cervical and cervicothoracic intraspinal subependymomas: a study of five cases. , 2016, Clinical radiology.

[8]  S. Powell,et al.  Recurrent subependymoma of fourth ventricle with unusual atypical histological features: A case report , 2015, Pathology international.

[9]  X. Ren,et al.  Clinical, radiological, and pathological features in 43 cases of intracranial subependymoma. , 2015, Journal of neurosurgery.

[10]  D. Áfra,et al.  Symptomatic subependymomas of the ventricles. Review of twenty consecutive cases. , 2014, Ideggyogyaszati szemle.

[11]  Liwei Zhang,et al.  Clinical features and management of intracranial subependymomas in children , 2013, Journal of Clinical Neuroscience.

[12]  Jun Yang,et al.  Surgical outcomes in spinal cord subependymomas: an institutional experience , 2013, Journal of Neuro-Oncology.

[13]  C. Bettegowda,et al.  Subependymoma: clinical features and surgical outcomes , 2012, Neurological research.

[14]  T. Pietsch,et al.  Surgical management of intracranial subependymomas , 2011, Acta Neurochirurgica.

[15]  V. P. Collins,et al.  Genome‐Wide Analysis of Subependymomas Shows Underlying Chromosomal Copy Number Changes Involving Chromosomes 6, 7, 8 and 14 in a Proportion of Cases , 2008, Brain pathology.

[16]  J. Ecklund,et al.  Subependymoma revisited: clinicopathological evaluation of 83 cases , 2007, Journal of Neuro-Oncology.

[17]  THOmS D. KncNEY,et al.  A STUDY OF FivE CASES , 2007 .

[18]  D. C. Henckel,et al.  Case report. , 1995, Journal.

[19]  I. Scheinker Subependymoma: A Newly Recognized Tumor of Subependymal Derivation , 1945 .

[20]  J. Sneep,et al.  With a summary , 1945 .